PT-141: a melanocortin agonist for the treatment of sexual dysfunction
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist that acts on the central nervous system to stimulate sexual arousal. The article reviews preclinical and early human studies demonstrating its ability to enhance erectile and sexual response through neurological pathways rather than vascular mechanisms.
BPC-157 Peptide Benefits: Healing, Reduced Inflammation, and Gut Health
BPC-157 is a synthetic peptide derived from a stomach protein that may support tissue repair, reduce inflammation, and improve digestive health. The article outlines its regenerative properties, potential to aid wound and soft tissue healing, and possible benefits for gut integrity and overall recovery, while noting that its use and safety require medical oversight.
Glucagon-Like Peptide-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of peptide-based medications used primarily to treat type 2 diabetes and obesity. They work by enhancing insulin secretion, lowering blood glucose, delaying gastric emptying, and promoting satiety. These agents also have beneficial effects on cardiovascular outcomes and are widely studied in metabolic disease management.
Therapeutic Peptides: Current Applications and Future Directions
This article highlights how novel design, synthesis, and modification technologies have expanded therapeutic peptide applications. It outlines progress in production methods, diverse natural and modified peptides, and current clinical uses, and discusses challenges and future opportunities in peptide drug discovery and optimization.
Peptides for Health Benefits 2020
This article highlights bioactive peptides’ therapeutic potential in drug discovery, chronic disease management, antimicrobial activity, metabolic regulation, food-derived peptides, and biomedical applications, demonstrating their versatility and growing importance across scientific disciplines.